Cases & Deals

Société Générale, Kempen, and Trout Capital complete €29.9 million private placement of new and secondary shares by DBV Technologies

Clients Société Générale SA, Kempen & Co., and Trout Capital

Jones Day represented Société Générale, Kempen & Co., and Trout Capital in connection with a €29.9 million (US$40.1 million) private placement of new and secondary shares by DBV Technologies, a biotech company specializing in food allergy with innovative products for diagnosis and treatment.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.